Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Urinary Bladder Neoplasms 1Surgery 1Sarcoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Ductal Adenocarcinoma 1Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer 1Multiple Myeloma 1Medulloblastoma 1Lung Neoplasms 1Liposarcoma 1Leiomyosarcoma 1HER2-positive Breast Cancer 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Breast Cancer Invasive 1

Interventions

Magnetic Resonance Spectroscopy 6X-Rays 5Phantoms, Imaging 5Nuclear Medicine Department, Hospital 5Specimen Handling 4Biopsy 4ulixertinib 2tipifarnib 2selpercatinib 2olaparib 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2Vincristine 2Temozolomide 2Cyclophosphamide 2Cisplatin 2tazemetostat 1palbociclib 1lutetium Lu 177 dotatate 1Vemurafenib 1Vascular Endothelial Growth Factor A 1Triiodothyronine 1Thiotepa 1Radiotherapy 1Radiation 1Platinum 1Pharmacogenomic Variants 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Medulloblastoma × Neoadjuvant Therapy × 30 days × Clear all
NCT02875314 2026-06-03

HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors

Nationwide Children's Hospital

Phase 4 Active not recruiting
250 enrolled
CNS

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡